91419-58-8

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(1H-tetrazol-5-yl)-, 1,1-dimethylethyl ester
• CAS NO: 91419-58-8
• Molecular Formula: C11H19N5O2
• Molecular Weight: 253.304
• Mol File: 91419-58-8.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(1H-tetrazol-5-yl)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(1H-tetrazol-5-yl)-, 1,1-dimethylethyl ester(91419-58-8)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(1H-tetrazol-5-yl)-, 1,1-dimethylethyl ester(91419-58-8)

Safety Data

• Hazardous Substances Data: 91419-58-8(Hazardous Substances Data)

Usage

Structure

A piperidine ring with a tetrazolyl group at position 4, and a tert-butoxycarbonyl (Boc) protecting group at the carboxylic acid functional group.

Role

Boc-Pip-ONH2 is a key intermediate in the synthesis of pharmaceuticals and organic compounds.

Usage

It is often used in peptide synthesis and as a building block in organic chemistry.

Importance

Boc-Pip-ONH2 is important for the development of new drugs and other biologically active compounds.

Upstream product

• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 17846-68-3 azido tributyltin (IV) 
• 39546-32-2 4-carboxamidopiperidine 
• 4395-98-6 4-cyanopiperidine 
• 91419-48-6 4-carbamoyl-piperidine-1-carboxylic acid tert-butyl ester 
• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 

Downstream Products

• 795310-82-6 tert-butyl 4-[2-(4-chlorobenzyl)-2H-tetrazole-5-yl]piperidine-1-carboxylate 
• 795310-83-7 tert-butyl 4-[1-(4-chlorobenzyl)-1H-tetrazole-5-yl]piperidine-1-carboxylate 
• 91419-60-2 4-(1H-tetrazol-5-yl)piperidine hydrochloride 

Relevant articles and documents

NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS

The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of b3-adrenoceptor. Formula (I).

NOVEL TRIAZOLOPYRIMIDINONE OR TRIAZOLOPYRIDINONE DERIVATIVES, AND USE THEREOF

The present invention relates to a novel triazolopyrimidinone or triazolopyridinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.

BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS.

This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1, or a salt thereof, wherein Q, R1 , R2, R3 and R4 are as defined herein.